Melanoma results from a complex interplay between environmental factors and individual genetic susceptibility. Familial melanoma is attributable to predisposition genes with variable penetrance. The aim of this study was to identify differences between familial melanoma and sporadic cases in our population, based on the presence of CDKN2A mutations and MC1R variants. Comparing 107 patients with familial melanoma from 87 families (17% CDKN2A mutated) with 1,390 cases of sporadic melanomas, the former were younger and exhibited an increased prevalence of atypical naevi and squamous cell carcinoma (SCC). CDKN2A mutation carriers presented more atypical naevi, multiple melanomas, and basal cell carcinoma, while non-carriers were more likely to ...
Mutations in the exons of the cyclin-dependent kinase inhibitor gene CDKN2A are melanoma-predisposit...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...
Approximately 5–10% of melanoma cases occur in a familial context. CDKN2A/CDK4 were the first high-p...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
The G101W founder mutation is the most common CDKN2A mutation in Italy, Spain, and France. As the ba...
Germline CDKN2A mutations have been described in 25% to 40% of melanoma families from several countr...
Germline CDKN2A mutations have been described in 25% to 40% of melanoma families from several countr...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Abstract Background Two high-risk genes have been implicated in the development of CM (cutaneous mel...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Mutations in the exons of the cyclin-dependent kinase inhibitor gene CDKN2A are melanoma-predisposit...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...
Approximately 5–10% of melanoma cases occur in a familial context. CDKN2A/CDK4 were the first high-p...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
The G101W founder mutation is the most common CDKN2A mutation in Italy, Spain, and France. As the ba...
Germline CDKN2A mutations have been described in 25% to 40% of melanoma families from several countr...
Germline CDKN2A mutations have been described in 25% to 40% of melanoma families from several countr...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Abstract Background Two high-risk genes have been implicated in the development of CM (cutaneous mel...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Mutations in the exons of the cyclin-dependent kinase inhibitor gene CDKN2A are melanoma-predisposit...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...